Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Comprehensive analysis of metabolism-related gene biomarkers reveals their impact on the diagnosis and prognosis of triple-negative breast cancer

Fig. 7

Immunotherapy response, drug treatment sensitivity, and immune response in high- and low-risk groups. (A) TIDE score. (B) Response to immunotherapy. (C) Sensitivity to drugs. (D) Stromal score, Immune score and ESTIMATE score. (E) Tumor purity. (F) Immune infiltration levels in high- and low-risk groups of TNBC patients determined via CIBERSORT

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us